AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Mithglim M 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Brightwell Pharma

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Mithglim M 2mg/500mg Tablet

Diabex Duo 2mg/500mg tablets are classified as antidiabetic medications, combining two active ingredients to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose levels. Diabex Duo should be taken with meals, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial, even with well-controlled blood sugar, as abrupt cessation can lead to elevated glucose, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication is part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are paramount in diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Be prepared to treat hypoglycemia by carrying fast-acting glucose sources like sugary snacks or juice. Alcohol increases this risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Individuals with a history of heart disease should inform their physician before starting treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Uses of Mithglim M 2mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of Mithglim M 2mg/500mg Tablet:

Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Mithglim M 2mg/500mg Tablet whole; do not break, crush, or chew it. Administer this medication with a meal.

Common Side effects of Mithglim M 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Mithglim M 2mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Mithglim M 2mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

How Mithglim M 2mg/500mg Tablet works:

Mithglim M 2mg/500mg tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose production, slowing intestinal glucose absorption, and enhancing the body's insulin response.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Mithglim M 2mg/500mg Tablets is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Mithglim M 2mg/500mg tablets during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Breastfeeding women should avoid Mithglim M 2mg/500mg tablets. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Mithglim M 2mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Mithglim M 2mg/500mg tablets. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Mithglim M 2mg/500mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For individuals with mild to moderate liver disease, a low initial dose is typically prescribed; however, its use is contraindicated in those with severe liver dysfunction.

What if you forget to take Mithglim M 2mg/500mg Tablet :

Should you forget to take your Mithglim M 2mg/500mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Mithglim M 2mg/500mg Tablet

LabelValue
Potential for Dependence None.
Type of Medication Medication for diabetes

FAQs on Mithglim M 2mg/500mg Tablet

Always keep this medication in its original, tightly sealed container. Follow the storage instructions printed on the packaging. Discard any remaining medicine. Ensure it remains inaccessible to children, pets, and others.
Mithglim M 2mg/500mg Tablets can cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is particularly concerning for individuals with kidney impairment, the elderly, or those who consume significant amounts of alcohol. Symptoms may include muscular discomfort or weakness, lightheadedness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or a slow pulse. The appearance of any of these symptoms necessitates immediate discontinuation of Mithglim M 2mg/500mg Tablets and prompt medical attention.
Each Mithglim M 2mg/500mg tablet combines glimepiride and metformin to manage type 2 diabetes mellitus in adults. This dual-action medication enhances blood sugar control when coupled with a balanced diet and physical activity. Glimepiride stimulates insulin secretion from the pancreas, while metformin reduces hepatic glucose production and increases insulin responsiveness. This formulation is unsuitable for type 1 diabetes.
Taking Mithglim M 2mg/500mg tablets may result in common side effects including low blood sugar, taste changes, nausea, abdominal discomfort, diarrhea, and headache. Rare but potentially serious side effects such as lactic acidosis are also possible. Prolonged use could additionally cause vitamin B12 deficiency.
Prolonged use of Mithglim M 2mg/500mg tablets can indeed lead to Vitamin B12 deficiency. This medication impairs Vitamin B12 absorption in the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications such as tingling and numbness in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive measures, according to some studies, include supplemental Vitamin B12 intake at least annually.
Indeed, Mithglim M 2mg/500mg Tablets may induce hypoglycemia (low blood glucose). Manifestations of low blood sugar encompass nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. This is more likely if meals are skipped or delayed, alcohol is consumed, excessive exercise is undertaken, or concomitant antidiabetic medication is used. Consequently, consistent blood glucose monitoring is crucial. Always carry a readily available fast-acting sugar source such as glucose tablets, honey, or fruit juice.
Combining Mithglim M 2mg/500mg tablets and alcohol is inadvisable due to the risk of dangerously low blood sugar (hypoglycemia). Concurrent use also elevates the likelihood of lactic acidosis.
Mithglim M 2mg/500mg Tabl...
115
MRP 140
17% off